LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Net Issuance of Common Stock Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Net Issuance of Common Stock
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Net Issuance of Common Stock
$3.7m
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
-19%
ProQR Therapeutics NV
NASDAQ:PRQR
Net Issuance of Common Stock
€528k
CAGR 3-Years
-82%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Net Issuance of Common Stock
$127k
CAGR 3-Years
-85%
CAGR 5-Years
-78%
CAGR 10-Years
-48%
argenx SE
XBRU:ARGX
Net Issuance of Common Stock
$1.3B
CAGR 3-Years
6%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Net Issuance of Common Stock
$487.8m
CAGR 3-Years
36%
CAGR 5-Years
123%
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Net Issuance of Common Stock?
Net Issuance of Common Stock
0 USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Net Issuance of Common Stock amounts to 0 USD.

Back to Top